Related Experiment Video

Updated: Jun 24, 2026

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
08:53

Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

Published on: August 31, 2016

Economic evaluation of peripheral blood stem cell transplantation for lymphoma

N H Russell, S Pacey

    Lancet (London, England)
    |November 21, 1992
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
    07:36

    Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

    Published on: June 12, 2021

    Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
    06:28

    Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

    Published on: November 10, 2023

    Related Experiment Videos

    Last Updated: Jun 24, 2026

    Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness
    08:53

    Competitive Transplants to Evaluate Hematopoietic Stem Cell Fitness

    Published on: August 31, 2016

    Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice
    07:36

    Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

    Published on: June 12, 2021

    Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis
    06:28

    Simplified Intrafemoral Injections Using Live Mice Allow for Continuous Bone Marrow Analysis

    Published on: November 10, 2023

    Related Concept Videos

    Bone Marrow Sampling and Transplants01:22

    Bone Marrow Sampling and Transplants

    Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
    The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy the...

    Articles linked to this work by shared authors, journal, and citation graph.

    Expanding PARP Inhibitor Use in Prostate Cancer Beyond DNA Repair Defects.

    Clinical oncology (Royal College of Radiologists (Great Britain))·2025

    Radioimmunotherapy-augmented BEAM chemotherapy vs BEAM alone as the high-dose regimen for autologous stem cell transplantation (ASCT) in relapsed follicular lymphoma (FL): a retrospective study of the EBMT Lymphoma Working Party.

    Bone marrow transplantation·2017

    Characteristics and outcome of patients with therapy-related acute promyelocytic leukemia front-line treated with or without arsenic trioxide.

    Leukemia·2017

    Recipient/donor HLA and CMV matching in recipients of T-cell-depleted unrelated donor haematopoietic cell transplants.

    Bone marrow transplantation·2017

    Long-term survival of patients with CLL after allogeneic transplantation: a report from the European Society for Blood and Marrow Transplantation.

    Bone marrow transplantation·2016

    Second malignancies in the context of lenalidomide treatment: an analysis of 2732 myeloma patients enrolled to the Myeloma XI trial.

    Blood cancer journal·2016

    Immunogenicity of fractional one-fifth and one-half doses of 17DD yellow fever vaccine compared with full dose in children aged 9-23 months in Uganda: a phase 4, single-blind, randomised clinical trial.

    Lancet (London, England)·2026

    Efficacy and safety of mitapivat in adults with transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial.

    Lancet (London, England)·2026

    Perioperative durvalumab plus fluorouracil, leucovorin, oxaliplatin, and docetaxel for resectable gastric and gastro-oesophageal junction adenocarcinoma (MATTERHORN): final results of overall survival and event-free survival by pathological response in a global, randomised, double-blind, placebo-controlled, multicentre, phase 3 trial.

    Lancet (London, England)·2026

    Wildfire smoke and health: current evidence, mechanisms, and future challenges.

    Lancet (London, England)·2026

    A study on the efficiency and spatial correlation of health resource allocation in Chinese hospitals.

    PloS one·2026

    Budget impact analysis for albuterol-budesonide fixed-dose combination in the as needed treatment of adult patients with asthma in Kuwait.

    Journal of medical economics·2026

    Addressing the failure of economic measures of value-for-money to reflect societal preferences for health and social care.

    Journal of health services research & policy·2026

    Establishing multiple cost-effectiveness thresholds in Oman: a stakeholder-driven approach.

    Health economics review·2026

    Fever of unknown origin: cost of illness study.

    Open medicine (Warsaw, Poland)·2026

    The potential usefulness of health asset valuation to promote health among Korean employees.

    Scientific reports·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us